US Stock MarketDetailed Quotes

KURA Kura Oncology

Watchlist
  • 9.010
  • +0.040+0.45%
Close Dec 20 16:00 ET
  • 9.174
  • +0.164+1.82%
Post 20:01 ET
700.65MMarket Cap-3.83P/E (TTM)

Kura Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kura Oncology Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.63
-0.63
-<0.01
Miss Est.
-25.21%
-26.00%
-0.66%
Analyst Rating
Strong Buy

Dec 22, 2024

Kura Oncology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 57.962M--
Nov 7, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 2, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 57.962M--
Nov 7, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 2, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Kura Oncology Earnings Reports

  • Kura Oncology | 10-Q: Q3 2024 Earnings Report

    Nov 7 16:22 ET

  • Kura Oncology | 8-K: Kura Oncology Reports Third Quarter 2024 Financial Results

    Nov 7 16:17 ET

  • Kura Oncology | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:22 ET

  • Kura Oncology | 8-K: Kura Oncology Reports Second Quarter 2024 Financial Results

    Aug 8 16:17 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 22, 2024

    Strong Buy

    • Buy

      86.67%

    • Hold

      13.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data